Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - TOTAL CURRENT LIABILITIES
Total Current Liabilities IKT - Inhibikase Therapeutics, Inc.
3.44 M
LAST VALUE
-7.91%
2 YEAR CAGR
-1.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR